Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes

  1. Garcia-Manero, G.
  2. Diez-Campelo, M.
  3. Vellenga, E.
  4. Jacoby, M.A.
  5. Merchan, B.
  6. Breems, D.
  7. Cortelezzi, A.
  8. Doronin, V.
  9. Gomez, V.
  10. Beckers, M.
  11. Della Porta, M.G.
  12. Varsos, H.
  13. Xiu, L.
  14. DeAngelis, N.
  15. Nnane, I.
  16. Rose, E.
  17. van Eygen, K.
Journal:
American Journal of Hematology

ISSN: 1096-8652 0361-8609

Year of publication: 2021

Volume: 96

Issue: 4

Pages: E111-E114

Type: Letter

DOI: 10.1002/AJH.26095 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals